Pharmacometrics summer internship at Boehringer Ingelheim US in 2020

The BI Pharmacometrics Group in Ridgefield, CT is looking for a talented PhD or MS student from the US to join us as intern over the summer in 2020. This is an exciting opportunity to gain insight into pharmaceutical industry and work on MID3 projects! https://boehringer.taleo.net/careersection/global+template+career+section+28external29/jobdetail.ftl?job=1913946&lang=en&sns_id=mailto#.XWbgzxT08_Q.mailto Benjamin Weber and I will be at ACoP next week and are happy to chat in person if you are interested in this opportunity. Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and communities. Summer Intern - Pharmacometrics-1913946 Description: Boehringer Ingelheim is currently seeking a talented and innovative Intern to join our Pharmacometrics Group located at our Ridgefield, CT facility. As an Intern, you will you will be assigned to your own pharmacometrics project and work under the supervision of an experienced pharmacometrician. The project scope includes but is not limited to performing hands-on pharmacometrics analysis in NONMEM and R based on pre-clinical and clinical pharmacokinetic/pharmacodymanic data and collaborating with other stakeholders in drug development. Ideally, the project results in a poster presentation or publication. As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees Duties & Responsibilities: Develop and qualify PK, PKPD and/or disease progression models including data set preparation and post-processing of software output Perform literature research to support model development and qualification Present project results and conclusions to Global Pharmacometrics Group and other stakeholders Summarize project results and conclusions in internal report and/or external poster/publication Requirements: Must be an Undergraduate, Graduate, or Professional Student in good academic standing. Must have completed 12 credit hours within a related major and/or other related coursework. Overall, cumulative GPA (from last completed quarter) must be at least 3.000 (on 4.0 scale) or better (No rounding up). Major must be related to the field of internship. Desired Experience, Skills and Abilities: * Hands-on experience in pharmacometrics software packages (e.g., NONMEM, R) * Basic knowledge in non-linear mixed effect modelling and biostatistics * Basic knowledge in clinical pharmacology and model informed drug discovery and development Eligibility Requirements: Must be legally authorized to work in the United States without restriction. Must be willing to take a drug test and post-offer physical (if required) Must be 18 years of age or older Who We Are: At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company we focus on long term performance. We are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key because your growth is our growth. Want to learn more? Visit http://www.boehringer-ingelheim.com/ and join us in our effort to make more health. Boehringer Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Ingelheim Animal Health USA, Inc., Merial Barceloneta, LLC and Boehringer Ingelheim Fremont, Inc. is an equal opportunity and affirmative action employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender identity or expression; affectional or sexual orientation; disability; veteran or military status, including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law. including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law. Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment verifications and drug screenings. Job - Apprenticeship/Internship Primary Location - Americas-US-CT-Ridgefield Organization - US-BI Pharma/BI USA Schedule - Full-time http://bit.ly/OJRIa8 Julia Korell, PhD Director, Pharmacometrics Translational Medicine & Clinical Pharmacology Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Connecticut * +1 (203) 791-6794 Ë +1 (203) 278-0683 * [email protected]<mailto:[email protected]> http://bit.ly/LO4IvZ [icon-linkedin.gif] http://linkd.in/LO4tAP [icon-youtube.gif] http://bit.ly/PJCrqF CONFIDENTIALITY NOTICE: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure of distribution is prohibited. If you are not the intended recipient, please contact sender by reply e-mail and destroy all copies of the original message.